APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felodipine Sustained-Release Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Felodipine Sustained-Release Tablet Market Outlook and Growth Opportunities 2026

31 December 2025192 pages

Choose your research edition.

Industry ResearchFelodipine Sustained-Release Tablet Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Felodipine Sustained-Release Tablet Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Felodipine Sustained-Release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felodipine Sustained-Release Tablet Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Felodipine Sustained-Release Tablet Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Felodipine Sustained-Release Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Felodipine Sustained-Release Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Felodipine Sustained-Release Tablet market include SHANXI KANGBO BIOLOGICAL PRODUCT, Sandoz, NanJing Easeheal Phaemaecutical, Mylan, Lifeon, Changzhou Siyao Pharmaceutical and Astrazeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Felodipine Sustained-Release Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Felodipine Sustained-Release Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Felodipine Sustained-Release Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Felodipine Sustained-Release Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Felodipine Sustained-Release Tablet Segment by Company

SHANXI KANGBO BIOLOGICAL PRODUCT

Sandoz

NanJing Easeheal Phaemaecutical

Mylan

Lifeon

Changzhou Siyao Pharmaceutical

Astrazeneca

Felodipine Sustained-Release Tablet Segment by Type

2.5mg Per Tablet

5mg Per Tablet

Others

Felodipine Sustained-Release Tablet Segment by Application

Treat High Blood Pressure

Relieve Angina

Others

Felodipine Sustained-Release Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Felodipine Sustained-Release Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Felodipine Sustained-Release Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Felodipine Sustained-Release Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Felodipine Sustained-Release Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felodipine Sustained-Release Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felodipine Sustained-Release Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felodipine Sustained-Release Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Felodipine Sustained-Release Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Felodipine Sustained-Release Tablet industry.

Chapter 3: Detailed analysis of Felodipine Sustained-Release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Felodipine Sustained-Release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Felodipine Sustained-Release Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Felodipine Sustained-Release Tablet Industry Trends Table 2. Felodipine Sustained-Release Tablet Industry Drivers Table 3. Felodipine Sustained-Release Tablet Industry Opportunities and Challenges Table 4. Felodipine Sustained-Release Tablet Industry Restraints Table 5. Global Felodipine Sustained-Release Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Felodipine Sustained-Release Tablet Revenue Share by Company (2021-2026) Table 7. Global Felodipine Sustained-Release Tablet Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Felodipine Sustained-Release Tablet Sales Volume Share by Company (2021-2026) Table 9. Global Felodipine Sustained-Release Tablet Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Felodipine Sustained-Release Tablet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Felodipine Sustained-Release Tablet Key Company Manufacturing Base & Headquarters Table 12. Global Felodipine Sustained-Release Tablet Company, Product Type & Application Table 13. Global Felodipine Sustained-Release Tablet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Felodipine Sustained-Release Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 2.5mg Per Tablet Table 18. Significant Companies of 5mg Per Tablet Table 19. Significant Companies of Others Table 20. Global Felodipine Sustained-Release Tablet Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Felodipine Sustained-Release Tablet Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Felodipine Sustained-Release Tablet Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Felodipine Sustained-Release Tablet Sales Volume Share by Type (2021-2026) Table 24. Global Felodipine Sustained-Release Tablet Sales Volume Share by Type (2027-2032) Table 25. Global Felodipine Sustained-Release Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Felodipine Sustained-Release Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Felodipine Sustained-Release Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Felodipine Sustained-Release Tablet Sales Value Share by Type (2021-2026) Table 29. Global Felodipine Sustained-Release Tablet Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Treat High Blood Pressure Table 31. Significant Companies of Relieve Angina Table 32. Significant Companies of Others Table 33. Global Felodipine Sustained-Release Tablet Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Felodipine Sustained-Release Tablet Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Felodipine Sustained-Release Tablet Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Felodipine Sustained-Release Tablet Sales Volume Share by Application (2021-2026) Table 37. Global Felodipine Sustained-Release Tablet Sales Volume Share by Application (2027-2032) Table 38. Global Felodipine Sustained-Release Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Felodipine Sustained-Release Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Felodipine Sustained-Release Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Felodipine Sustained-Release Tablet Sales Value Share by Application (2021-2026) Table 42. Global Felodipine Sustained-Release Tablet Sales Value Share by Application (2027-2032) Table 43. Global Felodipine Sustained-Release Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Felodipine Sustained-Release Tablet Sales by Region (2021-2026) & (K Units) Table 45. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2021-2026) Table 46. Global Felodipine Sustained-Release Tablet Sales by Region (2027-2032) & (K Units) Table 47. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2027-2032) Table 48. Global Felodipine Sustained-Release Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Felodipine Sustained-Release Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Felodipine Sustained-Release Tablet Sales Value Share by Region (2021-2026) Table 51. Global Felodipine Sustained-Release Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Felodipine Sustained-Release Tablet Sales Value Share by Region (2027-2032) Table 53. Global Felodipine Sustained-Release Tablet Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Felodipine Sustained-Release Tablet Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Felodipine Sustained-Release Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Felodipine Sustained-Release Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 58. Global Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2026) Table 59. Global Felodipine Sustained-Release Tablet Sales by Country (2027-2032) & (K Units) Table 60. Global Felodipine Sustained-Release Tablet Sales Market Share by Country (2027-2032) Table 61. Global Felodipine Sustained-Release Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Felodipine Sustained-Release Tablet Sales Value Market Share by Country (2021-2026) Table 63. Global Felodipine Sustained-Release Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Felodipine Sustained-Release Tablet Sales Value Market Share by Country (2027-2032) Table 65. SHANXI KANGBO BIOLOGICAL PRODUCT Company Information Table 66. SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview Table 67. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio Table 69. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Development Table 70. Sandoz Company Information Table 71. Sandoz Business Overview Table 72. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Sandoz Felodipine Sustained-Release Tablet Product Portfolio Table 74. Sandoz Recent Development Table 75. NanJing Easeheal Phaemaecutical Company Information Table 76. NanJing Easeheal Phaemaecutical Business Overview Table 77. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio Table 79. NanJing Easeheal Phaemaecutical Recent Development Table 80. Mylan Company Information Table 81. Mylan Business Overview Table 82. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Mylan Felodipine Sustained-Release Tablet Product Portfolio Table 84. Mylan Recent Development Table 85. Lifeon Company Information Table 86. Lifeon Business Overview Table 87. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Lifeon Felodipine Sustained-Release Tablet Product Portfolio Table 89. Lifeon Recent Development Table 90. Changzhou Siyao Pharmaceutical Company Information Table 91. Changzhou Siyao Pharmaceutical Business Overview Table 92. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio Table 94. Changzhou Siyao Pharmaceutical Recent Development Table 95. Astrazeneca Company Information Table 96. Astrazeneca Business Overview Table 97. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio Table 99. Astrazeneca Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Felodipine Sustained-Release Tablet Distributors List Table 103. Felodipine Sustained-Release Tablet Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Felodipine Sustained-Release Tablet Product Image Figure 2. Global Felodipine Sustained-Release Tablet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felodipine Sustained-Release Tablet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Felodipine Sustained-Release Tablet Sales (2021-2032) & (K Units) Figure 5. Global Felodipine Sustained-Release Tablet Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Felodipine Sustained-Release Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 2.5mg Per Tablet Image Figure 10. 5mg Per Tablet Image Figure 11. Others Image Figure 12. Global Felodipine Sustained-Release Tablet Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Felodipine Sustained-Release Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Felodipine Sustained-Release Tablet Sales Volume Share by Type (2021-2032) Figure 15. Global Felodipine Sustained-Release Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Felodipine Sustained-Release Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Felodipine Sustained-Release Tablet Sales Value Share by Type (2021-2032) Figure 18. Treat High Blood Pressure Image Figure 19. Relieve Angina Image Figure 20. Others Image Figure 21. Global Felodipine Sustained-Release Tablet Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Felodipine Sustained-Release Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Felodipine Sustained-Release Tablet Sales Volume Share by Application (2021-2032) Figure 24. Global Felodipine Sustained-Release Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Felodipine Sustained-Release Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Felodipine Sustained-Release Tablet Sales Value Share by Application (2021-2032) Figure 27. Global Felodipine Sustained-Release Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Felodipine Sustained-Release Tablet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Felodipine Sustained-Release Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Felodipine Sustained-Release Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Felodipine Sustained-Release Tablet Sales Value (2021-2032) & (US$ Million) Figure 32. North America Felodipine Sustained-Release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Felodipine Sustained-Release Tablet Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Felodipine Sustained-Release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Felodipine Sustained-Release Tablet Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Felodipine Sustained-Release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Felodipine Sustained-Release Tablet Sales Value (2021-2032) & (US$ Million) Figure 38. South America Felodipine Sustained-Release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Felodipine Sustained-Release Tablet Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Felodipine Sustained-Release Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Felodipine Sustained-Release Tablet Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Felodipine Sustained-Release Tablet Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg Per Tablet
  • 5mg Per Tablet
  • Others
Applications
  • Treat High Blood Pressure
  • Relieve Angina
  • Others
Companies covered
  • SHANXI KANGBO BIOLOGICAL PRODUCT
  • Sandoz
  • NanJing Easeheal Phaemaecutical
  • Mylan
  • Lifeon
  • Changzhou Siyao Pharmaceutical
  • Astrazeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Felodipine Sustained-Release Tablet Sales Value (2021-2032)
  4. 1.2.2 Global Felodipine Sustained-Release Tablet Sales Volume (2021-2032)
  5. 1.2.3 Global Felodipine Sustained-Release Tablet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Felodipine Sustained-Release Tablet Market Dynamics
  1. 2.1 Felodipine Sustained-Release Tablet Industry Trends
  2. 2.2 Felodipine Sustained-Release Tablet Industry Drivers
  3. 2.3 Felodipine Sustained-Release Tablet Industry Opportunities and Challenges
  4. 2.4 Felodipine Sustained-Release Tablet Industry Restraints
3 Felodipine Sustained-Release Tablet Market by Company
  1. 3.1 Global Felodipine Sustained-Release Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Felodipine Sustained-Release Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Felodipine Sustained-Release Tablet Sales Volume by Company (2021-2026)
  4. 3.4 Global Felodipine Sustained-Release Tablet Average Price by Company (2021-2026)
  5. 3.5 Global Felodipine Sustained-Release Tablet Company Ranking (2024-2026)
  6. 3.6 Global Felodipine Sustained-Release Tablet Company Manufacturing Base and Headquarters
  7. 3.7 Global Felodipine Sustained-Release Tablet Company Product Type and Application
  8. 3.8 Global Felodipine Sustained-Release Tablet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Felodipine Sustained-Release Tablet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Felodipine Sustained-Release Tablet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Felodipine Sustained-Release Tablet Market by Type
  1. 4.1 Felodipine Sustained-Release Tablet Type Introduction
  2. 4.1.1 2.5mg Per Tablet
  3. 4.1.2 5mg Per Tablet
  4. 4.1.3 Others
  5. 4.2 Global Felodipine Sustained-Release Tablet Sales Volume by Type
  6. 4.2.1 Global Felodipine Sustained-Release Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Felodipine Sustained-Release Tablet Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Felodipine Sustained-Release Tablet Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Felodipine Sustained-Release Tablet Sales Value by Type
  10. 4.3.1 Global Felodipine Sustained-Release Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Felodipine Sustained-Release Tablet Sales Value by Type (2021-2032)
  12. 4.3.3 Global Felodipine Sustained-Release Tablet Sales Value Share by Type (2021-2032)
5 Felodipine Sustained-Release Tablet Market by Application
  1. 5.1 Felodipine Sustained-Release Tablet Application Introduction
  2. 5.1.1 Treat High Blood Pressure
  3. 5.1.2 Relieve Angina
  4. 5.1.3 Others
  5. 5.2 Global Felodipine Sustained-Release Tablet Sales Volume by Application
  6. 5.2.1 Global Felodipine Sustained-Release Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Felodipine Sustained-Release Tablet Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Felodipine Sustained-Release Tablet Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Felodipine Sustained-Release Tablet Sales Value by Application
  10. 5.3.1 Global Felodipine Sustained-Release Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Felodipine Sustained-Release Tablet Sales Value by Application (2021-2032)
  12. 5.3.3 Global Felodipine Sustained-Release Tablet Sales Value Share by Application (2021-2032)
6 Felodipine Sustained-Release Tablet Regional Sales and Value Analysis
  1. 6.1 Global Felodipine Sustained-Release Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Felodipine Sustained-Release Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Felodipine Sustained-Release Tablet Sales by Region: 2021-2026
  4. 6.2.2 Global Felodipine Sustained-Release Tablet Sales by Region (2027-2032)
  5. 6.3 Global Felodipine Sustained-Release Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Felodipine Sustained-Release Tablet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Felodipine Sustained-Release Tablet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Felodipine Sustained-Release Tablet Sales Value by Region (2027-2032)
  9. 6.5 Global Felodipine Sustained-Release Tablet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Felodipine Sustained-Release Tablet Sales Value (2021-2032)
  12. 6.6.2 North America Felodipine Sustained-Release Tablet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Felodipine Sustained-Release Tablet Sales Value (2021-2032)
  15. 6.7.2 Europe Felodipine Sustained-Release Tablet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Felodipine Sustained-Release Tablet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Felodipine Sustained-Release Tablet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Felodipine Sustained-Release Tablet Sales Value (2021-2032)
  21. 6.9.2 South America Felodipine Sustained-Release Tablet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Felodipine Sustained-Release Tablet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Felodipine Sustained-Release Tablet Sales Value Share by Country, 2025 VS 2032
7 Felodipine Sustained-Release Tablet Country-level Sales and Value Analysis
  1. 7.1 Global Felodipine Sustained-Release Tablet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Felodipine Sustained-Release Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Felodipine Sustained-Release Tablet Sales by Country (2021-2032)
  4. 7.3.1 Global Felodipine Sustained-Release Tablet Sales by Country (2021-2026)
  5. 7.3.2 Global Felodipine Sustained-Release Tablet Sales by Country (2027-2032)
  6. 7.4 Global Felodipine Sustained-Release Tablet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Felodipine Sustained-Release Tablet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Felodipine Sustained-Release Tablet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Felodipine Sustained-Release Tablet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Felodipine Sustained-Release Tablet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Felodipine Sustained-Release Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SHANXI KANGBO BIOLOGICAL PRODUCT
  2. 8.1.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
  3. 8.1.2 SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview
  4. 8.1.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio
  6. 8.1.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Felodipine Sustained-Release Tablet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Felodipine Sustained-Release Tablet Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 NanJing Easeheal Phaemaecutical
  14. 8.3.1 NanJing Easeheal Phaemaecutical Company Information
  15. 8.3.2 NanJing Easeheal Phaemaecutical Business Overview
  16. 8.3.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio
  18. 8.3.5 NanJing Easeheal Phaemaecutical Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Felodipine Sustained-Release Tablet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Felodipine Sustained-Release Tablet Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Lifeon
  26. 8.5.1 Lifeon Company Information
  27. 8.5.2 Lifeon Business Overview
  28. 8.5.3 Lifeon Felodipine Sustained-Release Tablet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lifeon Felodipine Sustained-Release Tablet Product Portfolio
  30. 8.5.5 Lifeon Recent Developments
  31. 8.6 Changzhou Siyao Pharmaceutical
  32. 8.6.1 Changzhou Siyao Pharmaceutical Company Information
  33. 8.6.2 Changzhou Siyao Pharmaceutical Business Overview
  34. 8.6.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio
  36. 8.6.5 Changzhou Siyao Pharmaceutical Recent Developments
  37. 8.7 Astrazeneca
  38. 8.7.1 Astrazeneca Company Information
  39. 8.7.2 Astrazeneca Business Overview
  40. 8.7.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio
  42. 8.7.5 Astrazeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Felodipine Sustained-Release Tablet Value Chain Analysis
  2. 9.1.1 Felodipine Sustained-Release Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Felodipine Sustained-Release Tablet Sales Mode & Process
  6. 9.2 Felodipine Sustained-Release Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Felodipine Sustained-Release Tablet Distributors
  9. 9.2.3 Felodipine Sustained-Release Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst